Oct 2, 2023 | Analysis
In a new white paper, Alex Brill details the consequences of regulatory uncertainty for businesses and provides a close look at the ongoing uncertainty facing companies owned by ESOPs.
Aug 11, 2023 | Interviews
Alex Brill joined Kevin Price on ‘The Price of Business’ to discuss the fact that the US will add over $1 trillion to the deficit in a single year.
Aug 9, 2023 | Interviews
“Alex Brill, CEO of the economic consulting firm Matrix Global Advisors and a senior fellow at AEI, said it is “unnecessary” to require PBMs to pass the rebates along to plans.”
Jul 20, 2023 | News
MGA’s analysis of the competition as new adalimumab biosimilars enter market.
Jul 19, 2023 | Interviews
“The launches this month are “more of an inflection point in the market compared to what we saw in January when Amjevita came to market,” said Alex Brill.